Allarity Secures US Patent for Ovarian Cancer Companion Diagnostic Test
The patent covers a gene-expression profiling method designed to identify patients most likely to respond to the investigational therapy stenoparib through 2042.
Read More
Search Results for: lung cancer
GRAIL Secures $110 Million Investment from Samsung
GRAIL secured $110 million in equity financing from Samsung affiliates to support U.S. regulatory efforts and expand its Galleri multi-cancer early detection test into Asian markets, the companies announced.
Read More
New Study Links Biomarker Elevations to Kidney Transplant Failure Risk
Elevated donor-derived cell-free DNA levels are linked to higher kidney transplant failure risk, suggesting earlier detection of allograft injury before loss of kidney function.
Read More
New Imaging Technology Could Speed Up Cancer Diagnosis
Early results indicate the process could reduce sample preparation time by approximately 40% to 50%, while improving consistency by removing variability linked to staining conditions.
Read More
Early Lung Cancer Blood Test Completes US Laboratory Validation
The CIZ1B biomarker assay is designed to complement LDCT screening by helping assess lung cancer risk and clarify indeterminate findings.
Read More